ARTICLE | Financial News
Northwest Biotherapeutics postpones direct public offering
October 31, 2016 7:00 AM UTC
Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md.Business: CancerDate announced: 2016-10-27Type: Direct public offeringPlacement agent: Roth Capital PartnersInvestor: Institutional investorN...